A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.
Journal:
Journal of psychopharmacology (Oxford, England)
Published Date:
Jul 11, 2025
Abstract
BACKGROUND: Classic serotonergic psychedelics are 5-HT2A partial agonists that induce non-ordinary states of consciousness. Many have demonstrated anti-addictive properties; however, their impact on smoking behaviors remains under-researched. This review provides a synthesis of the therapeutic potential of these compounds in promoting smoking cessation and reduction.
Authors
Keywords
No keywords available for this article.